Back to search

Ireland· IE-PA-PA0074/011/001

Carbosan 2% w/w Gel

A carbenoxolone product containing carbenoxolone sodium, registered in Ireland by Rowa Pharmaceuticals Limited. The same ATC class is registered in 3 of our 19 countries.

ATC A02BX01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedCarbosan 2% w/w GelATCA02BX01REGISTER NO.IE-PA-PA0074/011/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Carbenoxolone is registered in 3 of 19 countries.

Countries holding a registration under ATC A02BX01 (carbenoxolone), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 1 of them publish a price we can compare per daily dose

Carbenoxolone · ATC A02BX01

3 / 19 countries

  • Finlandprice
  • Ireland
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
CARBENOXOLONE SODIUM
Manufacturer
Rowa Pharmaceuticals Limited
Country
Ireland (IE)
ATC code
A02BX01
ATC class
Carbenoxolone
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0074/011/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carbenoxolone in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carbenoxolone products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Hungary · Carbosan
  • Lithuania · Carbosan
  • Malta · Carbosan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/630eb890-1ebf-4237-8a01-66b3f0e01f8f
GET /v1/drugs/630eb890-1ebf-4237-8a01-66b3f0e01f8f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "routes": [
    "Cutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "A02BX01"
  ],
  "strength": null,
  "pa_number": "PA0074/011/001",
  "substances": [
    "CARBENOXOLONE SODIUM"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "13/03/1987",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about carbenoxolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.